Mersana Therapeutics, Inc.盘中异动急速下挫5.00%报2.19美元

市场透视12-13

北京时间2024年12月13日22时41分，Mersana Therapeutics, Inc.（MRSN.us）股票出现波动，股价大幅下跌5.00%。截至发稿，该股报2.19美元/股，成交量5.1159万股，换手率0.04%，振幅4.78%。最近的财报数据显示，该股实现营业收入12.60百万美元，净利润-11.50百万美元，每股收益-0.09美元，毛利12.20百万美元，市盈率-3.67倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2491137668?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-13 22:41","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2491137668","market":"us","top_or_hot":-1,"title":"Mersana Therapeutics, Inc.盘中异动 急速下挫5.00%报2.19美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月13日22时41分，Mersana Therapeutics, Inc.（MRSN.us）股票出现波动，股价大幅下跌5.00%。截至发稿，该股报2.19美元/股，成交量5.1159万股，换手率0.04%，振幅4.78%。最近的财报数据显示，该股实现营业收入12.60百万美元，净利润-11.50百万美元，每股收益-0.09美元，毛利12.20百万美元，市盈率-3.67倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322414995e9774b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mersana Therapeutics, Inc.盘中异动 急速下挫5.00%报2.19美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMersana Therapeutics, Inc.盘中异动 急速下挫5.00%报2.19美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-13 22:41 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322414995e9774b&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月13日22时41分，Mersana Therapeutics, Inc.（MRSN.us）股票出现波动，股价大幅下跌5.00%。截至发稿，该股报2.19美元/股，成交量5.1159万股，换手率0.04%，振幅4.78%。最近的财报数据显示，该股实现营业收入12.60百万美元，净利润-11.50百万美元，每股收益-0.09美元，毛利12.20百万美元，市盈率-3.67倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322414995e9774b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322414995e9774b&s=b","article_id":"2491137668","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121322414995e9774b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2491137668","pubTimestamp":1734100909,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月13日22时41分，Mersana Therapeutics, Inc.股票出现波动，股价大幅下跌5.00%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药有限公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","LENZ":"Therapeutics","BK4563":"昨日强势股","MRSN":"Mersana Therapeutics Inc."},"translate_title":"Mersana Therapeutics, Inc. fell 5.00% to $2.19 in intraday movements","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"MRSN":0.9},"content_text":"北京时间2024年12月13日22时41分，Mersana Therapeutics, Inc.（MRSN.us）股票出现波动，股价大幅下跌5.00%。截至发稿，该股报2.19美元/股，成交量5.1159万股，换手率0.04%，振幅4.78%。最近的财报数据显示，该股实现营业收入12.60百万美元，净利润-11.50百万美元，每股收益-0.09美元，毛利12.20百万美元，市盈率-3.67倍。机构评级方面，在所有10家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 (To Pur Com)、Oculis Holding Ag C/Wts 06/03/2028 (To Pur Ord)、Barinthus Biotherapeutics Plc涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为28.69%、23.20%、19.99%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 (To Pur Com)、Tc Biopharm (Holdings) Plc C/Wts 10/02/2028 (To Pur Ads)、X4制药，振幅分别为40.32%、39.33%、24.46%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药有限公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。 该公司的早期项目包括 XMT-1660（一种针对 B7-H4 的 Dolasynthen ADC）以及 XMT-2056（一种使用该公司的Immunosynthen平台开发的 STING 激动剂 ADC，针对人表皮生长因子受体 2 的新表位）。 还有两个早期临床前候选药物 XMT-2068 和 XMT-2175，两者都利用该公司的Immunosynthen 平台并针对肿瘤相关抗原。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2491137668"}

Mersana Therapeutics, Inc.盘中异动 急速下挫5.00%报2.19美元

精彩评论

Mersana Therapeutics, Inc.盘中异动急速下挫5.00%报2.19美元